Back to search

Aristotle University Of Thessaloniki (AUTH)

Μελέτη μεθυλίωσης γονιδίων-δεικτών καρκίνου ουροδόχου κύστης σε ούρα και ουροδόχο κύστη ασθενών με νευρογενή δυσλειτουργία του κατώτερου ουροποιητικού

Abstract

dc:description

DNA methylation is an epigenetic process occurs in genes’ promoters and results in the transcriptional silencing of genes. DNA methylation is a frequent event in bladder cancer, participating in tumor initiation and progression. Bladder cancer is a major health issue in patients suffering from neurogenic lower urinary tract dysfunction (NLUTD), although the pathogenetic mechanisms of the disease remain unclear. In this population, bladder cancer is characterized by aggressive histopathology, advanced stage during diagnosis, and high mortality rates. Currently, there is a scarcity of specific guidelines for bladder cancer screening and the development of urine biomarkers for bladder cancer seems to be an attractive non-invasive method of screening or risk stratification in this patient population. The objective of this study was the investigation of DNA hypermethylation in five gene promoters (RASSF1, APC, DAPK, RARβ, TERT), previously associated with bladder cancer, in the urine of NLUTD patients, and in comparison with healthy individuals, and in bladder tissue of NLUTD patients. This was a prospective case–control study that recruited neurourology outpatients who had suffered from NLUTD for at least 5 years. They all underwent cystoscopy and biopsy for bladder cancer screening following written informed consent. DNA was extracted from urine samples of patients and controls and from the available bladder tissue samples of patients. The DNA methylation status of the RASSF1, RARβ, DAPK, TERT and APC gene promoters was assessed via quantitative methylation-specific PCR. In this study, 41 patients of mixed NLUTD etiology and 35 controls were enrolled. DNA was detected in 36 patients’ urine specimens and in those of 22 controls. In the urine samples, DNA was hypermethylated in at least one of five gene promoters in 17/36 patients and in 3/22 controls (47.22% vs. 13.64%, respectively, p = 0.009). RASSF1 was hypermethylated in 10/17 (58.82%) urine samples with DNA detection, APC in 7/17 (41.18%), DAPK in 4/17 (23.53%), RARβ in 3/17 (17.56%) and TERT in none urine sample. According to a multivariate logistic regression analysis, NLUTD and male gender were significantly associated with hypermethylation (OR = 7.43, p = 0.007 and OR = 4.21; p = 0.04, respectively). In the tissue samples, DNA hypermethylation was detected in at least one gene promoter of the panel in all tissue samples. RARβ was hypermethylated in 22/24 (91.67%) tissue samples, RASSF1 and DAPK were hypermethylated in 20/24 (83.33%), APC in 9/24 (37.5%), and TERT in none of the tissue samples. Histology revealed TaLG BCa in two (4,88%) patients and urothelial squamous metaplasia in five (12,2%) patients. Chronic bladder inflammation was present in bladder biopsies of 35 (85,37%) patients. In conclusion, DNA hypermethylation in a panel of five genes promoters, previously associated with bladder cancer, in the urine was significantly more frequent in NLUTD patients than in the controls. We also observed high rates of DNA hypermethylation in bladder tissue, suggesting an epigenetic field effect and possible risk of bladder cancer development. Further research is needed to assess the clinical implications and possible associations between DNA hypermethylation, recurrent urinary tract infections, chronic inflammation and bladder cancer etiopathogenesis in NLUTD patients.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Koukourikis, Periklis
  • Κουκουρίκης, Περικλής

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/58581

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Koukourikis, Periklis; Κουκουρίκης, Περικλής. Μελέτη μεθυλίωσης γονιδίων-δεικτών καρκίνου ουροδόχου κύστης σε ούρα και ουροδόχο κύστη ασθενών με νευρογενή δυσλειτουργία του κατώτερου ουροποιητικού. Aristotle University Of Thessaloniki (AUTH), 2025. http://hdl.handle.net/10442/hedi/58581